These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 28636736
1. The protective effect of intratympanic dexamethasone on streptomycin ototoxicity in rats. Gül A, Şengül E, Yılmaz B, Özkurt FE, Akdağ M, Keleş A, Topçu İ. Ear Nose Throat J; 2017 Jun; 96(6):E12-E17. PubMed ID: 28636736 [Abstract] [Full Text] [Related]
2. Comparison of the protective efficacy between intratympanic dexamethasone and resveratrol treatments against cisplatin-induced ototoxicity: an experimental study. Simsek G, Taş BM, Muluk NB, Azman M, Kılıç R. Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3287-3293. PubMed ID: 31531774 [Abstract] [Full Text] [Related]
5. The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigs. Daldal A, Odabasi O, Serbetcioglu B. Otolaryngol Head Neck Surg; 2007 Nov; 137(5):747-52. PubMed ID: 17967639 [Abstract] [Full Text] [Related]
7. Effects of ozone (O3) therapy on cisplatin-induced ototoxicity in rats. Koçak HE, Taşkın Ü, Aydın S, Oktay MF, Altınay S, Çelik DS, Yücebaş K, Altaş B. Eur Arch Otorhinolaryngol; 2016 Dec; 273(12):4153-4159. PubMed ID: 27221387 [Abstract] [Full Text] [Related]
8. Efficacy of 2 Different Intratympanic Steroid Regimen on Prevention of Cisplatin Ototoxicity: An Experimental Study. Taş BM, Şimşek G, Azman M, Kılıç R. Ear Nose Throat J; 2021 Jul; 100(6):417-422. PubMed ID: 31569969 [Abstract] [Full Text] [Related]
10. Comparison of the protective effects of intratympanic dexamethasone and methylprednisolone against cisplatin-induced ototoxicity. Özel HE, Özdoğan F, Gürgen SG, Esen E, Genç S, Selçuk A. J Laryngol Otol; 2016 Mar; 130(3):225-34. PubMed ID: 26830667 [Abstract] [Full Text] [Related]
11. Effects of intratympanic dexamethasone on noise-induced hearing loss: An experimental study. Gumrukcu SS, Topaloglu İ, Salturk Z, Tutar B, Atar Y, Berkiten G, Göker AE. Am J Otolaryngol; 2018 Mar; 39(1):71-73. PubMed ID: 29110919 [Abstract] [Full Text] [Related]
12. Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model. Gozeler MS, Ekinci Akdemir FN, Yildirim S, Sahin A, Eser G, Askin S. Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():70-75. PubMed ID: 30978472 [Abstract] [Full Text] [Related]
16. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia]. Lisowska G, Namysłowski G, Hajduk A, Polok A, Tomaszewska R, Misiołek M. Otolaryngol Pol; 2006 Apr; 60(3):415-20. PubMed ID: 16989457 [Abstract] [Full Text] [Related]
17. Effects of a dexamethasone-releasing implant on cochleae: A functional, morphological and pharmacokinetic study. Liu Y, Jolly C, Braun S, Janssen T, Scherer E, Steinhoff J, Ebenhoch H, Lohner A, Stark T, Kiefer J. Hear Res; 2015 Sep; 327():89-101. PubMed ID: 25987502 [Abstract] [Full Text] [Related]
18. Ototoxicity screening of patients treated with streptomycin using distortion product otoacoustic emissions. Md Daud MK, Mohamadl H, Haron A, Rahman NA. B-ENT; 2014 Sep; 10(1):53-8. PubMed ID: 24765829 [Abstract] [Full Text] [Related]
19. Protective role of misoprostol in prevention of gentamicin ototoxicity. Dogan M, Polat H, Yasar M, Bayram A, Karatas D, Hira İ, Kale A, Senel F, Özcan İ. Int J Pediatr Otorhinolaryngol; 2017 May; 96():140-144. PubMed ID: 28390604 [Abstract] [Full Text] [Related]